Abiozen’s Super Generic API division is built to deliver at scale—without sacrificing precision, speed, or regulatory compliance. Leveraging state-of-the-art manufacturing infrastructure, we produce high-volume APIs that meet the demands of both emerging and established markets. Our synthesis lines are powered by advanced automation, continuous flow chemistry, and reactor systems engineered to maximize throughput while maintaining strict control over product quality and consistency.

Batch-to-Batch Consistency

Quality and consistency are the cornerstones of our manufacturing process. Through advanced automation and process control systems, we eliminate production variability and ensure each batch of API mirrors the last in quality, purity, and performance. Inspired by Thermo Fisher Patheon’s best-in-class development practices, our integrated controls monitor critical parameters in real time—enabling immediate corrections and predictive quality assurance across every run.

Scalable Production Infrastructure

Our facilities are designed with scalability at their core. Whether supporting early-stage clinical development or responding to commercial-scale demand surges, Abiozen’s modular production lines can be rapidly adjusted to align with evolving client requirements. Drawing from Curia Global’s manufacturing agility, our scalable infrastructure enables faster transitions from lab to launch, shortening time-to-market and supporting a wider product portfolio.

Real-Time Monitoring and Process Optimization

Continuous oversight is vital in ensuring quality and reducing production costs. Our manufacturing systems are equipped with integrated sensors and analytics platforms that monitor yield, purity, temperature, pressure, and flow rates in real time. Inspired by Thermo Fisher CRDMO’s precision-first philosophy, these systems empower our teams to make data-driven adjustments on the fly—resulting in more efficient production cycles and reduced waste.

Continuous Flow Chemistry Advantage

By employing continuous flow chemistry alongside traditional batch processes, Abiozen significantly shortens synthesis timelines and reduces overhead. This modern approach improves reaction efficiency, reduces solvent use, and enhances safety—all while enabling rapid scale-up without requiring revalidation of core processes. This positions us not only as a technology leader but as a cost-effective partner for high-volume API production.

Strategic Outcome

With our high-volume synthesis capabilities, Abiozen empowers pharmaceutical partners to deliver affordable, high-quality medications at scale—faster, safer, and more reliably than traditional API suppliers. Whether launching a new super generic or expanding into new markets, our clients trust us to provide the manufacturing backbone that supports regulatory success, operational efficiency, and commercial growth.